Halozyme Therapeutics, Inc. (LON:0J2O)
77.11
-2.98 (-3.72%)
Feb 12, 2026, 5:07 PM GMT
Halozyme Therapeutics Employees
Halozyme Therapeutics had 350 employees as of December 31, 2024. The number of employees decreased by 23 or -6.17% compared to the previous year.
Employees
350
Change (1Y)
-23
Growth (1Y)
-6.17%
Revenue / Employee
2.64M GBP
Profits / Employee
1.27M GBP
Market Cap
6.85B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 350 | -23 | -6.17% |
| Dec 31, 2023 | 373 | -20 | -5.09% |
| Dec 31, 2022 | 393 | 248 | 171.03% |
| Dec 31, 2021 | 145 | 9 | 6.62% |
| Dec 31, 2020 | 136 | 4 | 3.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,000 |
| Convatec Group | 10,000 |
| Hikma Pharmaceuticals | 9,500 |
| CVS Group | 8,850 |
| Genus | 3,190 |
Halozyme Therapeutics News
- 9 days ago - Halozyme Therapeutics: Key Acquisitions To Help Drive Long-Term Growth - Seeking Alpha
- 10 days ago - IBD Stock Of The Day Halozyme Eyes Two Buy Points; How It's 'Layering' Up For Future Growth - Investor's Business Daily
- 15 days ago - Halozyme Therapeutics Inc Investor Call Transcript - GuruFocus
- 15 days ago - Halozyme Therapeutics Projects Sustained Growth Well Into 2040 - Benzinga
- 15 days ago - Halozyme Therapeutics, Inc. (HALO) Q4 2025 Sales/Trading Call Transcript - Seeking Alpha
- 15 days ago - Halozyme Therapeutics, Inc. (HALO) 2025 Sales/ Trading Statement Call - Slideshow - Seeking Alpha
- 15 days ago - Enhanced Guidance Boosts Halozyme's (HALO) Growth Prospects - GuruFocus
- 15 days ago - Halozyme (HALO) Projects Strong Revenue Growth for FY26 - GuruFocus